Research · head to head
DNAnexus vs Form Bio
DNAnexus
Research
Regulated cloud platform for genomic and multiomic data, with GxP and FedRAMP coverage
- From
- On request
- Rated
- -
Form Bio
Research
Computational platform for cell and gene therapy design and manufacturability
- From
- On request
- Rated
- -
The short version
- Each has a real cost: DNAnexus no pricing is published, so an organisation cannot compare the total cost against running the same pipelines on its own cloud account until it is deep in a sales process.; Form Bio the company has pivoted twice since spinning out of Colossal Biosciences in 2022, from general computational life sciences to cell and gene therapy and then to AAV manufacturability, so any evaluation more than a year old describes a product that is no longer the commercial focus.
- They diverge on capability: DNAnexus covers Governed data storage, Form Bio covers FormManufacturing.
- Prices and features above were last checked on 31 August 2026.
Where they differ
Only the attributes on which DNAnexus and Form Bio actually diverge.
Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Research).
What each one covers
Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.
Only in DNAnexus
- Governed data storage
- Workflow execution
- App building
- Controlled collaboration
- Compliance posture
- Cohort browsing
Only in Form Bio
- FormManufacturing
- Payload design optimisation
- Genome integrity analysis
- Manufacturability prediction
- In silico workflows
- Scale-up monitoring
- Cell and gene therapy focus
- Collaboration
What people use each for
The jobs each tool is most often brought in to do.
DNAnexus
- A clinical diagnostics laboratory that needs a CLIA and CAP aligned environment for production sequencing pipelines without building the compliance evidence itselfnot Form Bio
- A pharma sponsor analysing genomic endpoints in a registrational programme where 21 CFR Part 11 records are requirednot Form Bio
- A biobank or consortium giving hundreds of external researchers governed access to a dataset too large to distributenot Form Bio
- A diagnostics vendor packaging its pipeline as a versioned app so partner laboratories can run it without receiving the source codenot Form Bio
Form Bio
- A gene therapy developer discovering manufacturability problems with an AAV construct late in process development and wanting to move that analysis earliernot DNAnexus
- A biotech comparing several candidate payload designs in silico before committing to expensive production runsnot DNAnexus
- A CDMO characterising what a client construct actually produces against what was specifiednot DNAnexus
- A programme team needing genome integrity evidence to support regulatory conversations about product consistencynot DNAnexus
Where each one falls short
Documented limitations, not opinions. Every one is a constraint you would hit in normal use.
DNAnexus
- No pricing is published, so an organisation cannot compare the total cost against running the same pipelines on its own cloud account until it is deep in a sales process.
- Compute and storage are billed through the platform rather than at underlying cloud list price, so the compliance envelope carries a persistent margin on every terabyte and core hour, which grows with the science rather than staying fixed.
- Data egress at genomic scale is slow and chargeable, so leaving the platform later is a real project rather than a contract decision, and that gravity weakens negotiating position at renewal.
- The regulated and validated configurations sit in a higher commercial tier than the research configuration, so an organisation that starts in research mode and later needs GxP faces a repricing rather than a setting change.
- Bioinformaticians used to running Nextflow on their own infrastructure find the platform abstractions constraining, and porting an existing pipeline into the app model is engineering work that does not carry over to any other platform.
Form Bio
- The company has pivoted twice since spinning out of Colossal Biosciences in 2022, from general computational life sciences to cell and gene therapy and then to AAV manufacturability, so any evaluation more than a year old describes a product that is no longer the commercial focus.
- The current offering launched AAV-focused, so developers working in lentiviral, mRNA or cell therapy modalities are outside the scope the platform was built and validated for.
- No pricing is published and engagements are scoped per programme, which makes it impossible to size the commitment before entering a sales process.
- This is a young venture-funded company whose analyses feed regulatory-facing decisions, so continuity of the vendor over a multi-year development programme is a genuine diligence question rather than a formality.
- Predictive manufacturability models need real production data to be trustworthy, and the value depends on how much of that a young vendor has accumulated, which is difficult for a buyer to verify independently.
Pricing, plan by plan
DNAnexus
On request- DNAnexus Platform$undefined/year
- Quoted per organisation through a sales process
- Storage and compute billed through the platform rather than at cloud list price
- Regulated and validated configurations are a separate commercial tier
Form Bio
On request- FormManufacturing$undefined/year
- Pricing only through a sales process
- Scoped per therapeutic programme rather than per seat
- AAV-focused offering at launch
Which should you pick?
Choose DNAnexus if
- You need governed data storage.
- You work on Web, Linux.
- You also want workflow execution.
Choose Form Bio if
- You need formmanufacturing.
- You work on Web, Cloud.
- You also want payload design optimisation.
Questions people ask
- Is DNAnexus or Form Bio better?
- Neither clearly leads. DNAnexus starts at On request and Form Bio at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
- Which is cheaper, DNAnexus or Form Bio?
- DNAnexus starts at On request and Form Bio at On request.
- Does DNAnexus or Form Bio run on more platforms?
- DNAnexus runs on Web, Linux. Form Bio runs on Web, Cloud.
- What is DNAnexus best used for?
- DNAnexus is most often used for a clinical diagnostics laboratory that needs a clia and cap aligned environment for production sequencing pipelines without building the compliance evidence itself, a pharma sponsor analysing genomic endpoints in a registrational programme where 21 cfr part 11 records are required, a biobank or consortium giving hundreds of external researchers governed access to a dataset too large to distribute, a diagnostics vendor packaging its pipeline as a versioned app so partner laboratories can run it without receiving the source code. Of those, a clinical diagnostics laboratory that needs a clia and cap aligned environment for production sequencing pipelines without building the compliance evidence itself and a pharma sponsor analysing genomic endpoints in a registrational programme where 21 cfr part 11 records are required are not what Form Bio is typically brought in for.
- What can DNAnexus do that Form Bio cannot?
- DNAnexus covers Governed data storage, Workflow execution, App building, Controlled collaboration. Form Bio covers FormManufacturing, Payload design optimisation, Genome integrity analysis, Manufacturability prediction.
Answered from the vendors’ own pages
DNAnexus: Why pay for DNAnexus instead of raw AWS?
For the compliance evidence. GxP, FedRAMP, CLIA, CAP and Part 11 coverage removes a validation programme most organisations would otherwise have to build and maintain themselves.
Form Bio: What does Form Bio sell now?
FormManufacturing, launched in 2026, an AAV-focused platform for predicting, optimising and monitoring manufacturability of genetic medicines from construct design through scale-up.
DNAnexus: Is validated use included?
No. Regulated and validated configurations sit in a separate commercial tier from ordinary research use.
Form Bio: Is it still a general bioinformatics platform?
No. It has narrowed from broad computational life sciences tooling to cell and gene therapy, and within that to AAV.
DNAnexus: Can I get my data out?
Yes, but egress at genomic scale is chargeable and slow, so plan exit costs at the point of signing.
Form Bio: Where did the company come from?
It spun out of Colossal Biosciences in 2022.
DNAnexus: Does it host UK Biobank?
Yes, DNAnexus hosts the UK Biobank research analysis platform, which has its own access approval and cost terms.
Form Bio: Is pricing published?
No. Engagements are scoped per programme through a sales process.
Related pages
Other head to heads
- DNAnexus vs Benchling
- DNAnexus vs Terra
- DNAnexus vs Seven Bridges
- DNAnexus vs Labguru
- DNAnexus vs Dotmatics
- DNAnexus vs TetraScience
- DNAnexus vs Schrodinger
- DNAnexus vs LabWare
- DNAnexus vs STARLIMS
- DNAnexus vs Castor EDC
- DNAnexus vs Condens
- DNAnexus vs SurveySparrow
- DNAnexus vs Contentsquare
- DNAnexus vs LabArchives
- DNAnexus vs NVivo
- DNAnexus vs GWI
- DNAnexus vs Aurelius
- DNAnexus vs OpenEye, Cadence Molecular Sciences
- DNAnexus vs Sapio Sciences
- DNAnexus vs Mouseflow
- DNAnexus vs Chemaxon
- DNAnexus vs Obsidian
- DNAnexus vs Paperpile
- DNAnexus vs Reduct
- DNAnexus vs Remesh
- DNAnexus vs Scispot
- Form Bio vs Benchling
- Form Bio vs Terra
- Form Bio vs Seven Bridges
- Form Bio vs Labguru
- Form Bio vs Dotmatics
- Form Bio vs TetraScience
- Form Bio vs Schrodinger
- Form Bio vs LabWare
- Form Bio vs STARLIMS
- Form Bio vs Castor EDC
- Form Bio vs Condens
- Form Bio vs SurveySparrow
- Form Bio vs Contentsquare
- Form Bio vs LabArchives
- Form Bio vs NVivo
- Form Bio vs GWI
- Form Bio vs Aurelius
- Form Bio vs OpenEye, Cadence Molecular Sciences
- Form Bio vs Sapio Sciences
- Form Bio vs Mouseflow
- Form Bio vs Chemaxon
- Form Bio vs Obsidian
- Form Bio vs Paperpile
- Form Bio vs Reduct
- Form Bio vs Remesh
- Form Bio vs Scispot